Loading…

Various scoring systems evaluating histologic features of chronic hepatitis C treated with interferon

Various scoring systems for chronic hepatitis have been proposed; however, there is no standard scoring system for studies of interferon (IFN) therapy in patients with chronic hepatitis C. The aims of this study were to determine the most useful system reflecting histologic changes in biopsy specime...

Full description

Saved in:
Bibliographic Details
Published in:Human pathology 2001-09, Vol.32 (9), p.910-917
Main Authors: Ikawa, Hirotsugu, Hayashi, Yoshitake, Ninomiya, Toshiaki, Yano, Yoshihiko, Nakaji, Miyuki, Nagano, Hidenobu, Seo, Yasushi, Kumon, Yoshiko, Yoon, Seitetsu, Kasuga, Masato, Itoh, Hiroshi, Ohbayashi, Chiho
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c402t-5fcd4a33458c732a66590a921f55dc2d2bb936a67307881654e3be10aabbdd313
cites cdi_FETCH-LOGICAL-c402t-5fcd4a33458c732a66590a921f55dc2d2bb936a67307881654e3be10aabbdd313
container_end_page 917
container_issue 9
container_start_page 910
container_title Human pathology
container_volume 32
creator Ikawa, Hirotsugu
Hayashi, Yoshitake
Ninomiya, Toshiaki
Yano, Yoshihiko
Nakaji, Miyuki
Nagano, Hidenobu
Seo, Yasushi
Kumon, Yoshiko
Yoon, Seitetsu
Kasuga, Masato
Itoh, Hiroshi
Ohbayashi, Chiho
description Various scoring systems for chronic hepatitis have been proposed; however, there is no standard scoring system for studies of interferon (IFN) therapy in patients with chronic hepatitis C. The aims of this study were to determine the most useful system reflecting histologic changes in biopsy specimens from complete responders and predicting the efficacy of IFN therapy. Patients with chronic hepatitis C were administered IFN-α for 6 months. Forty-six patients were included in this study and categorized as complete responders (n = 15), partial responders (n = 24), and nonresponders (n = 7) according to viral and biochemical responses to the therapy. Biopsy specimens obtained from each patient before and after treatment were evaluated under 3 different systems: Histological Activity Index (HAI), modified HAI, and Scheuer classification. Complete responders showed considerable improvement in both grade and stage on the modified HAI and Scheuer classifications. On the HAI, a considerable improvement was observed in grade but not in stage. No significant change was observed in partial responders or nonresponders on any system. Prediction of complete response was not possible under any system, but the pretreatment score reflecting piecemeal necrosis on any 1 of the 3 classifications and the fibrosis score on Scheuer classification were predictors of nonresponse. The modified HAI system and Scheuer classification were amply useful in evaluating histologic changes in complete responders. Scores higher than 4 of the categories reflecting piecemeal necrosis on any system and fibrosis scores of 3 or 4 on Scheuer classification predicted nonresponse to IFN therapy. HUM PATHOL 32:910-917. Copyright © 2001 by W.B. Saunders Company
doi_str_mv 10.1053/hupa.2001.27108
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71182087</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0046817701568768</els_id><sourcerecordid>71182087</sourcerecordid><originalsourceid>FETCH-LOGICAL-c402t-5fcd4a33458c732a66590a921f55dc2d2bb936a67307881654e3be10aabbdd313</originalsourceid><addsrcrecordid>eNp10E1P3DAQgGGrAsEWOPdW-UJvWfwRx8kRreiHhNRL4Wo59oS4ysaLx6Hi3-NlV-LUk6XR45H9EvKFszVnSt6My86uBWN8LTRn7Sey4kqKqpWdOCErxuqmarnW5-Qz4t_CuKrVGTkvZ6MF71YEHm0KcUGKLqYwP1F8xQxbpPBip8Xm_WgMmOMUn4KjA9i8JEAaB-rGFOcyG2FXXA5INzSnAsDTfyGPNMwZ0gBFXZLTwU4IV8fzgjx8v_uz-Vnd__7xa3N7X7maiVypwfnaSlmr1mkpbNOojtlO8EEp74QXfd_JxjZaMt22vFE1yB44s7bvvZdcXpBvh727FJ8XwGy2AR1Mk52hfNJozlvBWl3gzQG6FBETDGaXwtamV8OZ2Zc1-7JmX9a8ly03vh5XL_0W_Ic_pizg-ggsOjsNyc4u4IerOdO8ZsV1BwclxEuAZNAFmB34kMBl42P47yPeALPSlpQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71182087</pqid></control><display><type>article</type><title>Various scoring systems evaluating histologic features of chronic hepatitis C treated with interferon</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Ikawa, Hirotsugu ; Hayashi, Yoshitake ; Ninomiya, Toshiaki ; Yano, Yoshihiko ; Nakaji, Miyuki ; Nagano, Hidenobu ; Seo, Yasushi ; Kumon, Yoshiko ; Yoon, Seitetsu ; Kasuga, Masato ; Itoh, Hiroshi ; Ohbayashi, Chiho</creator><creatorcontrib>Ikawa, Hirotsugu ; Hayashi, Yoshitake ; Ninomiya, Toshiaki ; Yano, Yoshihiko ; Nakaji, Miyuki ; Nagano, Hidenobu ; Seo, Yasushi ; Kumon, Yoshiko ; Yoon, Seitetsu ; Kasuga, Masato ; Itoh, Hiroshi ; Ohbayashi, Chiho</creatorcontrib><description>Various scoring systems for chronic hepatitis have been proposed; however, there is no standard scoring system for studies of interferon (IFN) therapy in patients with chronic hepatitis C. The aims of this study were to determine the most useful system reflecting histologic changes in biopsy specimens from complete responders and predicting the efficacy of IFN therapy. Patients with chronic hepatitis C were administered IFN-α for 6 months. Forty-six patients were included in this study and categorized as complete responders (n = 15), partial responders (n = 24), and nonresponders (n = 7) according to viral and biochemical responses to the therapy. Biopsy specimens obtained from each patient before and after treatment were evaluated under 3 different systems: Histological Activity Index (HAI), modified HAI, and Scheuer classification. Complete responders showed considerable improvement in both grade and stage on the modified HAI and Scheuer classifications. On the HAI, a considerable improvement was observed in grade but not in stage. No significant change was observed in partial responders or nonresponders on any system. Prediction of complete response was not possible under any system, but the pretreatment score reflecting piecemeal necrosis on any 1 of the 3 classifications and the fibrosis score on Scheuer classification were predictors of nonresponse. The modified HAI system and Scheuer classification were amply useful in evaluating histologic changes in complete responders. Scores higher than 4 of the categories reflecting piecemeal necrosis on any system and fibrosis scores of 3 or 4 on Scheuer classification predicted nonresponse to IFN therapy. HUM PATHOL 32:910-917. Copyright © 2001 by W.B. Saunders Company</description><identifier>ISSN: 0046-8177</identifier><identifier>EISSN: 1532-8392</identifier><identifier>DOI: 10.1053/hupa.2001.27108</identifier><identifier>PMID: 11567219</identifier><identifier>CODEN: HPCQA4</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adult ; Aged ; Antiviral Agents - therapeutic use ; Biological and medical sciences ; Biopsy ; chronic hepatitis C ; Disease Progression ; False Positive Reactions ; Female ; Hepatitis C, Chronic - drug therapy ; Hepatitis C, Chronic - pathology ; histology ; Human viral diseases ; Humans ; Infectious diseases ; interferon therapy ; Interferon-alpha - therapeutic use ; Male ; Medical sciences ; Middle Aged ; Pathology, Surgical - methods ; Predictive Value of Tests ; scoring system ; Treatment Outcome ; Viral diseases ; Viral hepatitis</subject><ispartof>Human pathology, 2001-09, Vol.32 (9), p.910-917</ispartof><rights>2001 W.B. Saunders Company</rights><rights>2002 INIST-CNRS</rights><rights>Copyright 2001 by W.B. Saunders Company</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c402t-5fcd4a33458c732a66590a921f55dc2d2bb936a67307881654e3be10aabbdd313</citedby><cites>FETCH-LOGICAL-c402t-5fcd4a33458c732a66590a921f55dc2d2bb936a67307881654e3be10aabbdd313</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14107140$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11567219$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ikawa, Hirotsugu</creatorcontrib><creatorcontrib>Hayashi, Yoshitake</creatorcontrib><creatorcontrib>Ninomiya, Toshiaki</creatorcontrib><creatorcontrib>Yano, Yoshihiko</creatorcontrib><creatorcontrib>Nakaji, Miyuki</creatorcontrib><creatorcontrib>Nagano, Hidenobu</creatorcontrib><creatorcontrib>Seo, Yasushi</creatorcontrib><creatorcontrib>Kumon, Yoshiko</creatorcontrib><creatorcontrib>Yoon, Seitetsu</creatorcontrib><creatorcontrib>Kasuga, Masato</creatorcontrib><creatorcontrib>Itoh, Hiroshi</creatorcontrib><creatorcontrib>Ohbayashi, Chiho</creatorcontrib><title>Various scoring systems evaluating histologic features of chronic hepatitis C treated with interferon</title><title>Human pathology</title><addtitle>Hum Pathol</addtitle><description>Various scoring systems for chronic hepatitis have been proposed; however, there is no standard scoring system for studies of interferon (IFN) therapy in patients with chronic hepatitis C. The aims of this study were to determine the most useful system reflecting histologic changes in biopsy specimens from complete responders and predicting the efficacy of IFN therapy. Patients with chronic hepatitis C were administered IFN-α for 6 months. Forty-six patients were included in this study and categorized as complete responders (n = 15), partial responders (n = 24), and nonresponders (n = 7) according to viral and biochemical responses to the therapy. Biopsy specimens obtained from each patient before and after treatment were evaluated under 3 different systems: Histological Activity Index (HAI), modified HAI, and Scheuer classification. Complete responders showed considerable improvement in both grade and stage on the modified HAI and Scheuer classifications. On the HAI, a considerable improvement was observed in grade but not in stage. No significant change was observed in partial responders or nonresponders on any system. Prediction of complete response was not possible under any system, but the pretreatment score reflecting piecemeal necrosis on any 1 of the 3 classifications and the fibrosis score on Scheuer classification were predictors of nonresponse. The modified HAI system and Scheuer classification were amply useful in evaluating histologic changes in complete responders. Scores higher than 4 of the categories reflecting piecemeal necrosis on any system and fibrosis scores of 3 or 4 on Scheuer classification predicted nonresponse to IFN therapy. HUM PATHOL 32:910-917. Copyright © 2001 by W.B. Saunders Company</description><subject>Adult</subject><subject>Aged</subject><subject>Antiviral Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Biopsy</subject><subject>chronic hepatitis C</subject><subject>Disease Progression</subject><subject>False Positive Reactions</subject><subject>Female</subject><subject>Hepatitis C, Chronic - drug therapy</subject><subject>Hepatitis C, Chronic - pathology</subject><subject>histology</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>interferon therapy</subject><subject>Interferon-alpha - therapeutic use</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pathology, Surgical - methods</subject><subject>Predictive Value of Tests</subject><subject>scoring system</subject><subject>Treatment Outcome</subject><subject>Viral diseases</subject><subject>Viral hepatitis</subject><issn>0046-8177</issn><issn>1532-8392</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNp10E1P3DAQgGGrAsEWOPdW-UJvWfwRx8kRreiHhNRL4Wo59oS4ysaLx6Hi3-NlV-LUk6XR45H9EvKFszVnSt6My86uBWN8LTRn7Sey4kqKqpWdOCErxuqmarnW5-Qz4t_CuKrVGTkvZ6MF71YEHm0KcUGKLqYwP1F8xQxbpPBip8Xm_WgMmOMUn4KjA9i8JEAaB-rGFOcyG2FXXA5INzSnAsDTfyGPNMwZ0gBFXZLTwU4IV8fzgjx8v_uz-Vnd__7xa3N7X7maiVypwfnaSlmr1mkpbNOojtlO8EEp74QXfd_JxjZaMt22vFE1yB44s7bvvZdcXpBvh727FJ8XwGy2AR1Mk52hfNJozlvBWl3gzQG6FBETDGaXwtamV8OZ2Zc1-7JmX9a8ly03vh5XL_0W_Ic_pizg-ggsOjsNyc4u4IerOdO8ZsV1BwclxEuAZNAFmB34kMBl42P47yPeALPSlpQ</recordid><startdate>20010901</startdate><enddate>20010901</enddate><creator>Ikawa, Hirotsugu</creator><creator>Hayashi, Yoshitake</creator><creator>Ninomiya, Toshiaki</creator><creator>Yano, Yoshihiko</creator><creator>Nakaji, Miyuki</creator><creator>Nagano, Hidenobu</creator><creator>Seo, Yasushi</creator><creator>Kumon, Yoshiko</creator><creator>Yoon, Seitetsu</creator><creator>Kasuga, Masato</creator><creator>Itoh, Hiroshi</creator><creator>Ohbayashi, Chiho</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010901</creationdate><title>Various scoring systems evaluating histologic features of chronic hepatitis C treated with interferon</title><author>Ikawa, Hirotsugu ; Hayashi, Yoshitake ; Ninomiya, Toshiaki ; Yano, Yoshihiko ; Nakaji, Miyuki ; Nagano, Hidenobu ; Seo, Yasushi ; Kumon, Yoshiko ; Yoon, Seitetsu ; Kasuga, Masato ; Itoh, Hiroshi ; Ohbayashi, Chiho</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c402t-5fcd4a33458c732a66590a921f55dc2d2bb936a67307881654e3be10aabbdd313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antiviral Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Biopsy</topic><topic>chronic hepatitis C</topic><topic>Disease Progression</topic><topic>False Positive Reactions</topic><topic>Female</topic><topic>Hepatitis C, Chronic - drug therapy</topic><topic>Hepatitis C, Chronic - pathology</topic><topic>histology</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>interferon therapy</topic><topic>Interferon-alpha - therapeutic use</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pathology, Surgical - methods</topic><topic>Predictive Value of Tests</topic><topic>scoring system</topic><topic>Treatment Outcome</topic><topic>Viral diseases</topic><topic>Viral hepatitis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ikawa, Hirotsugu</creatorcontrib><creatorcontrib>Hayashi, Yoshitake</creatorcontrib><creatorcontrib>Ninomiya, Toshiaki</creatorcontrib><creatorcontrib>Yano, Yoshihiko</creatorcontrib><creatorcontrib>Nakaji, Miyuki</creatorcontrib><creatorcontrib>Nagano, Hidenobu</creatorcontrib><creatorcontrib>Seo, Yasushi</creatorcontrib><creatorcontrib>Kumon, Yoshiko</creatorcontrib><creatorcontrib>Yoon, Seitetsu</creatorcontrib><creatorcontrib>Kasuga, Masato</creatorcontrib><creatorcontrib>Itoh, Hiroshi</creatorcontrib><creatorcontrib>Ohbayashi, Chiho</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Human pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ikawa, Hirotsugu</au><au>Hayashi, Yoshitake</au><au>Ninomiya, Toshiaki</au><au>Yano, Yoshihiko</au><au>Nakaji, Miyuki</au><au>Nagano, Hidenobu</au><au>Seo, Yasushi</au><au>Kumon, Yoshiko</au><au>Yoon, Seitetsu</au><au>Kasuga, Masato</au><au>Itoh, Hiroshi</au><au>Ohbayashi, Chiho</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Various scoring systems evaluating histologic features of chronic hepatitis C treated with interferon</atitle><jtitle>Human pathology</jtitle><addtitle>Hum Pathol</addtitle><date>2001-09-01</date><risdate>2001</risdate><volume>32</volume><issue>9</issue><spage>910</spage><epage>917</epage><pages>910-917</pages><issn>0046-8177</issn><eissn>1532-8392</eissn><coden>HPCQA4</coden><abstract>Various scoring systems for chronic hepatitis have been proposed; however, there is no standard scoring system for studies of interferon (IFN) therapy in patients with chronic hepatitis C. The aims of this study were to determine the most useful system reflecting histologic changes in biopsy specimens from complete responders and predicting the efficacy of IFN therapy. Patients with chronic hepatitis C were administered IFN-α for 6 months. Forty-six patients were included in this study and categorized as complete responders (n = 15), partial responders (n = 24), and nonresponders (n = 7) according to viral and biochemical responses to the therapy. Biopsy specimens obtained from each patient before and after treatment were evaluated under 3 different systems: Histological Activity Index (HAI), modified HAI, and Scheuer classification. Complete responders showed considerable improvement in both grade and stage on the modified HAI and Scheuer classifications. On the HAI, a considerable improvement was observed in grade but not in stage. No significant change was observed in partial responders or nonresponders on any system. Prediction of complete response was not possible under any system, but the pretreatment score reflecting piecemeal necrosis on any 1 of the 3 classifications and the fibrosis score on Scheuer classification were predictors of nonresponse. The modified HAI system and Scheuer classification were amply useful in evaluating histologic changes in complete responders. Scores higher than 4 of the categories reflecting piecemeal necrosis on any system and fibrosis scores of 3 or 4 on Scheuer classification predicted nonresponse to IFN therapy. HUM PATHOL 32:910-917. Copyright © 2001 by W.B. Saunders Company</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>11567219</pmid><doi>10.1053/hupa.2001.27108</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0046-8177
ispartof Human pathology, 2001-09, Vol.32 (9), p.910-917
issn 0046-8177
1532-8392
language eng
recordid cdi_proquest_miscellaneous_71182087
source ScienceDirect Freedom Collection 2022-2024
subjects Adult
Aged
Antiviral Agents - therapeutic use
Biological and medical sciences
Biopsy
chronic hepatitis C
Disease Progression
False Positive Reactions
Female
Hepatitis C, Chronic - drug therapy
Hepatitis C, Chronic - pathology
histology
Human viral diseases
Humans
Infectious diseases
interferon therapy
Interferon-alpha - therapeutic use
Male
Medical sciences
Middle Aged
Pathology, Surgical - methods
Predictive Value of Tests
scoring system
Treatment Outcome
Viral diseases
Viral hepatitis
title Various scoring systems evaluating histologic features of chronic hepatitis C treated with interferon
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T03%3A19%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Various%20scoring%20systems%20evaluating%20histologic%20features%20of%20chronic%20hepatitis%20C%20treated%20with%20interferon&rft.jtitle=Human%20pathology&rft.au=Ikawa,%20Hirotsugu&rft.date=2001-09-01&rft.volume=32&rft.issue=9&rft.spage=910&rft.epage=917&rft.pages=910-917&rft.issn=0046-8177&rft.eissn=1532-8392&rft.coden=HPCQA4&rft_id=info:doi/10.1053/hupa.2001.27108&rft_dat=%3Cproquest_cross%3E71182087%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c402t-5fcd4a33458c732a66590a921f55dc2d2bb936a67307881654e3be10aabbdd313%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=71182087&rft_id=info:pmid/11567219&rfr_iscdi=true